Erasca ERAS
NASDAQ ERAS
$14.91 +0.34 (+2.30%)
As of: Oct 2, 2026 · 11:38 AM EDT

Erasca (ERAS) Cash from Financing Activities (2020 - 2026)

Updated

Erasca's Cash from Financing Activities came in at $3.06 million for Q2 2026, up 585.5% from $447,000 a year earlier but down 98.7% from the prior quarter.

Analysis

Erasca (ERAS) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Erasca reported Cash from Financing Activities of $248.34 million; for FY2025, it came in at $1.1 million, down 99.5% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of -62.1% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $240.7 million in FY2024, $1.3 million in FY2023 (-98.7%), $98.08 million in FY2022 (-77.7%) and $439.4 million in FY2021 (+213.9%).
  • The five-year range for quarterly Cash from Financing Activities is $7,000 (Q3 2023) to $317.57 million (Q3 2021).
  • Year-over-year, Cash from Financing Activities increased in two of the last six quarters, with growth averaging 55.6%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2026 (growth of 585.5%), and the weakest in Q3 2022 (a decline of 99.9%).
  • Business Quant data shows ERAS's Cash from Financing Activities at $244.66 million (Q1 2026), $575,000 (Q4 2025) and $41,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Erasca 4.58 Bn 4.58 Bn - 3.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.06 Mn
Mar 31, 2026 244.66 Mn
Dec 31, 2025 575,000.00
Sep 30, 2025 41,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 33,000.00
Dec 31, 2024 801,000.00
Sep 30, 2024 21.10 Mn
Jun 30, 2024 211.87 Mn
Mar 31, 2024 6.93 Mn
Dec 31, 2023 456,000.00
Sep 30, 2023 7,000.00
Jun 30, 2023 649,000.00
Mar 31, 2023 183,000.00
Dec 31, 2022 96.20 Mn
Sep 30, 2022 427,000.00
Jun 30, 2022 992,000.00
Mar 31, 2022 460,000.00
Dec 31, 2021 1.11 Mn
Sep 30, 2021 317.57 Mn
API Access

Erasca Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ERAS&period=max&api_key=YOUR_API_KEY